California's Proposition 71
GPTKB entity
Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
ballot measure
|
| gptkbp:aimsTo |
medical research
|
| gptkbp:associated_with |
public health initiatives
biomedical research |
| gptkbp:collaborations |
universities and private sector
|
| gptkbp:contributedTo |
job creation in biotech
|
| gptkbp:court |
multiple times
|
| gptkbp:criticism |
taxpayer groups
|
| gptkbp:designedBy |
California_voters
|
| gptkbp:duration |
10 years
|
| gptkbp:established |
gptkb:California_Institute_for_Regenerative_Medicine
|
| gptkbp:funding |
stem cell research
|
| gptkbp:has_a_focus_on |
journalists
|
| gptkbp:has_implications_for |
clinical trials
patient care disease treatment research funding models future medical treatments |
| https://www.w3.org/2000/01/rdf-schema#label |
California's Proposition 71
|
| gptkbp:influence |
shaping public opinion
|
| gptkbp:influenced |
ethical debates
similar initiatives in other states |
| gptkbp:is_a_key_component_of |
California's_innovation_strategy
|
| gptkbp:is_a_model_for |
other states
|
| gptkbp:is_a_subject_of |
public debate
legal challenges |
| gptkbp:is_essential_for |
California's_research_landscape
|
| gptkbp:is_evaluated_by |
research institutions
|
| gptkbp:is_featured_in |
media coverage
|
| gptkbp:is_funded_by |
state bonds
|
| gptkbp:is_linked_to |
ethical funding practices
|
| gptkbp:is_monitored_by |
California_Institute_for_Regenerative_Medicine_Board
|
| gptkbp:is_part_of |
biomedical ethics
healthcare_funding California's_health_policy |
| gptkbp:is_recognized_for |
its impact on science policy
|
| gptkbp:is_studied_in |
policy experts
|
| gptkbp:is_supported_by |
gptkb:Governor_Arnold_Schwarzenegger
patient advocacy groups scientific community California_state_government |
| gptkbp:is_used_in |
academic research
legislative hearings federal policies on stem cell research scientific funding ethics stem cell legislation |
| gptkbp:keyEvent |
California_politics
|
| gptkbp:landmark |
legislation
|
| gptkbp:led_to |
advancements in regenerative medicine
|
| gptkbp:opposedBy |
pro-life groups
|
| gptkbp:passesThrough |
November 2, 2004
|
| gptkbp:produces |
public interest
|
| gptkbp:receives_funding_from |
$3 billion
|
| gptkbp:related_to |
stem cell therapy
|
| gptkbp:resultedIn |
numerous research grants
|
| gptkbp:supports |
scientific research
|
| gptkbp:was_a_catalyst_for |
innovation in healthcare
|
| gptkbp:was_a_factor_in |
California's_economy
|
| gptkbp:was_a_response_to |
federal funding limitations
California's_Proposition_200 |